Access the full text.
Sign up today, get DeepDyve free for 14 days.
Lei Wang, Wenjun Zhang, Yi Ding, B. Xiu, Ping Li, Yan Dong, Q. Zhu, A. Liang (2015)
Up-regulation of VEGF and its receptor in refractory leukemia cells.International journal of clinical and experimental pathology, 8 5
B. Guerra, B. Boldyreff, O. Issinger (2001)
FAS-associated factor 1 interacts with protein kinase CK2 in vivo upon apoptosis induction.International journal of oncology, 19 6
S. Kim, H. Choi, Ho‐Jeong Lee, Junqin He, Qiuyu Wu, R. Langley, I. Fidler, Sun-jin Kim (2014)
Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells.Neuro-oncology, 16 12
P. Nia, J. Hendriks, G. Friedel, P. Schil, E. Marck (2007)
Distinct angiogenic and non‐angiogenic growth patterns of lung metastases from renal cell carcinomaHistopathology, 51
R. Langley, D. Fan, R. Tsan, Robert Rebhun, Junqin He, Sun-jin Kim, I. Fidler (2004)
Activation of the Platelet-Derived Growth Factor-Receptor Enhances Survival of Murine Bone Endothelial Cells 1Cancer Research, 64
I. Zachary, G. Gliki (2001)
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.Cardiovascular research, 49 3
A. Chambers, A. Groom, I. Macdonald (2002)
Metastasis: Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2
E. Ades, F. Candal, R. Swerlick, V. George, Susan Summers, D. Bosse, T. Lawley (1992)
HMEC-1: establishment of an immortalized human microvascular endothelial cell line.The Journal of investigative dermatology, 99 6
E. Chavakis, S. Dimmeler (2002)
Regulation of Endothelial Cell Survival and Apoptosis During AngiogenesisArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 22
S. Lee, M. Shin, W. Park, S. Kim, S. Dong, H. Lee, J. Park, Ro Oh, Ja-june Jang, Jung Lee, N. Yoo (1999)
Immunohistochemical analysis of Fas ligand expression in normal human tissuesAPMIS, 107
M. Álvarez, Luciana Gutierrez, J. Auzmendi, A. Correa, A. Lazarowski, M. Bolontrade (2020)
Acquisition of stem associated-features on metastatic osteosarcoma cells and their functional effects on mesenchymal stem cells.Biochimica et biophysica acta. General subjects
A. Logan (1993)
AngiogenesisThe Lancet, 341
Fuwang Peng, N. Dhillon, Shannon Callen, Honghong Yao, S. Bokhari, Xuhui Zhu, H. Baydoun, S. Buch (2011)
Platelet-derived growth factor protects neurons against gp120-mediated toxicityJournal of NeuroVirology, 14
P. Carmeliet (2000)
Mechanisms of angiogenesis and arteriogenesisNature Medicine, 6
D. Hanahan, L. Coussens
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types
Paul Daft, Yang Yang, D. Napierała, M. Zayzafoon (2015)
The Growth and Aggressive Behavior of Human Osteosarcoma Is Regulated by a CaMKII-Controlled Autocrine VEGF Signaling MechanismPLoS ONE, 10
A. Angulski, L. Capriglione, Michel Batista, B. Marcon, A. Senegaglia, M. Stimamiglio, A. Correa (2017)
The Protein Content of Extracellular Vesicles Derived from Expanded Human Umbilical Cord Blood-Derived CD133+ and Human Bone Marrow-Derived Mesenchymal Stem Cells Partially Explains Why both Sources are Advantageous for Regenerative MedicineStem Cell Reviews and Reports, 13
S. Bielack, B. Kempf‐Bielack, G. Delling, G. Exner, S. Flege, K. Helmke, R. Kotz, M. Salzer‐Kuntschik, M. Werner, W. Winkelmann, A. Zoubek, H. Jürgens, K. Winkler (2002)
Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 3
M. Bolontrade, M. Stern, R. Binder, J. Zenklusen, I. Gimenez-Conti, C. Conti (1998)
Angiogenesis is an early event in the development of chemically induced skin tumors.Carcinogenesis, 19 12
N. Weidner, J. Semple, W. Welch, J. Folkman (1991)
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.The New England journal of medicine, 324 1
N. Calvo, P. Carriere, María Martín, G. Gigola, C. Gentili (2019)
PTHrP treatment of colon cancer cells promotes tumor associated-angiogenesis by the effect of VEGFMolecular and Cellular Endocrinology, 483
V. Mohan, Alakesh Das, I. Sagi (2020)
Emerging roles of ECM remodeling processes in cancer.Seminars in cancer biology
S. Weis, D. Cheresh (2005)
Pathophysiological consequences of VEGF-induced vascular permeabilityNature, 437
D. Vitale, F. Spinelli, Daiana Dago, Antonella Icardi, Gianina Demarchi, Ilaria Caon, Mariana Garcia, M. Bolontrade, A. Passi, C. Cristina, L. Alaniz (2018)
Co-treatment of tumor cells with hyaluronan plus doxorubicin affects endothelial cell behavior independently of VEGF expressionOncotarget, 9
Natalia Papadopoulos, J. Lennartsson (2017)
The PDGF/PDGFR pathway as a drug target.Molecular aspects of medicine, 62
J. Cox, M. Mann (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 26
J Folkman (2006)
10.1146/annurev.med.57.121304.131306Annu Rev Med, 57
G. Wang, M. Humayun (1996)
Induction of theMolecular Genetics and Genomics, 251
Mariana Garcia, L. Alaniz, E. Lopes, G. Blanco, S. Hajos, É. Álvarez (2005)
Inhibition of NF-κB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell linesLeukemia Research, 29
B. Hoang, J. Dyke, J. Koutcher, A. Huvos, H. Mizobuchi, Beth Mazza, R. Gorlick, J. Healey (2004)
VEGF Expression in Osteosarcoma Correlates with Vascular Permeability by Dynamic MRIClinical Orthopaedics and Related Research, 1
Graham Pidgeon, Martin Barr, Judith Harmey, Deirdre Foley, D. Bouchier‐Hayes (2001)
Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cellsBritish Journal of Cancer, 85
M. Bolontrade, L. Sganga, E. Piaggio, D. Viale, M. Sorrentino, A. Robinson, G. Sevlever, Mariana Garcia, G. Mazzolini, O. Podhajcer (2012)
A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus.Stem cells and development, 21 14
M. Cortini, S. Avnet, N. Baldini (2017)
Mesenchymal stroma: Role in osteosarcoma progression.Cancer letters, 405
N. Hempel, T. Bartling, B. Mian, J. Melendez (2013)
Acquisition of the Metastatic Phenotype Is Accompanied by H2O2-Dependent Activation of the p130Cas Signaling ComplexMolecular Cancer Research, 11
C. Heldin, B. Westermark (1999)
Mechanism of action and in vivo role of platelet-derived growth factor.Physiological reviews, 79 4
F. Pezzella, U. Pastorino, E. Tagliabue, S. Andreola, G. Sozzi, G. Gasparini, S. Ménard, K. Gatter, A. Harris, Steve Fox, M. Buyse, S. Pilotti, M. Pierotti, F. Rilke (1997)
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.The American journal of pathology, 151 5
S. Jia, L. Worth, E. Kleinerman (2004)
A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategiesClinical & Experimental Metastasis, 17
A. Mammoto, T. Mammoto (2019)
Vascular Niche in Lung Alveolar Development, Homeostasis, and RegenerationFrontiers in Bioengineering and Biotechnology, 7
Boris Strilic, S. Offermanns (2017)
Intravascular Survival and Extravasation of Tumor Cells.Cancer cell, 32 3
D Hanahan (2012)
10.1016/j.ccr.2012.02.022Cancer Cell, 21
Craig Menges, D. Altomare, J. Testa (2009)
FAS-Associated Factor 1 (FAF1): Diverse functions and implications for oncogenesisCell Cycle, 8
Changhan Lee, F. Safdie, L. Raffaghello, Min Wei, F. Madia, Edoardo Parrella, David Hwang, P. Cohen, G. Bianchi, V. Longo (2010)
Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index.Cancer research, 70 4
R. Labiche, Robert Tresslert, G. Nicolson (1993)
Selection for enhanced adhesion to microvessel endothelial cells or resistance to interferon-γ modulates the metastatic potential of murine RAW117 large-cell lymphoma cellsClinical & Experimental Metastasis, 11
X. Chen, Ju-Ock Nam, C. Jean, C. Lawson, C. Walsh, Erik Goka, S. Lim, Alok Tomar, Isabelle Tancioni, S. Uryu, J. Guan, Lisette Acevedo, S. Weis, D. Cheresh, D. Schlaepfer (2012)
VEGF-induced vascular permeability is mediated by FAK.Developmental cell, 22 1
L Zhang (2011)
10.1091/mbc.e10-12-0985Mol Biol Cell, 22
A. Passaniti, R. Taylor, R. Pili, Yu’e Guo, P. Long, J. Haney, R. Pauly, D. Grant, G. Martin (1992)
A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.Laboratory investigation; a journal of technical methods and pathology, 67 4
W. Degen, L. Kempen, Erwin Gijzen, J. Groningen, Y. van, Kooyk, H. Bloemers, G. Swart (1998)
MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).The American journal of pathology, 152 3
Ali Yilmaz, S. Kliche, Ulrike Mayr-Beyrle, G. Fellbrich, J. Waltenberger (2003)
p38 MAPK inhibition is critically involved in VEGFR-2-mediated endothelial cell survival.Biochemical and biophysical research communications, 306 3
Harold Dvorak, Harold Dvorak (2000)
VPF/VEGF and the angiogenic response.Seminars in perinatology, 24 1
J. Knowles, M. Loizidou, I. Taylor (2005)
Endothelin-1 and angiogenesis in cancer.Current vascular pharmacology, 3 4
(2011)
Fas-associated factor 1 antagonizes Wnt signaling by promoting β-catenin degradation
Arthur Lambert, D. Pattabiraman, R. Weinberg (2017)
Emerging Biological Principles of MetastasisCell, 168
A. Alfranca, L. Martinez-Cruzado, Juan Tornín, Ander Abarrategi, T. Amaral, E. Álava, P. Menéndez, J. García-Castro, R. Rodríguez (2015)
Bone microenvironment signals in osteosarcoma developmentCellular and Molecular Life Sciences, 72
Feng Xie, Ke Jin, L. Shao, Yao-min Fan, Yifei Tu, Yihao Li, B. Yang, H. Dam, P. Dijke, H. Weng, S. Dooley, Shuai Wang, Junling Jia, Jin Jin, Fangfang Zhou, Long Zhang (2017)
FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasisNature Communications, 8
W. Aird (2007)
Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and MechanismsCirculation Research, 100
M. Eppihimer, J. Russell, R. Langley, G. Vallien, D. Anderson, D. Granger (1998)
Differential Expression of Platelet‐Endothelial Cell Adhesion Molecule‐1 (PECAM‐1) in Murine TissuesMicrocirculation, 5
N. Weidner, J. Folkman, F. Pozza, P. Bevilacqua, E. Allred, D. Moore, S. Meli, G. Gasparini (1992)
Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.Journal of the National Cancer Institute, 84 24
Amanda Hansen, Shanna Arnold, M. Jiang, T. Palmer, T. Ketova, A. Merkel, Michael Pickup, S. Samaras, Y. Shyr, H. Moses, S. Hayward, J. Sterling, A. Zijlstra (2014)
ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.Cancer research, 74 5
J. Harmey, D. Bouchier‐Hayes (2002)
Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy.BioEssays : news and reviews in molecular, cellular and developmental biology, 24 3
D. Matei, S. Kelich, Liyun Cao, N. Menning, R. Emerson, Jyiannu Rao, M. Jeng, G. Sledge (2007)
PDGF BB induces VEGF secretion in ovarian cancerCancer Biology & Therapy, 6
Elizabeth Lafleur, N. Koshkina, John Stewart, S. Jia, L. Worth, X. Duan, E. Kleinerman (2004)
Increased Fas Expression Reduces the Metastatic Potential of Human Osteosarcoma CellsClinical Cancer Research, 10
I. Fidler (2003)
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisitedNature Reviews Cancer, 3
Wen-ting Xu, Zhen-yu Bian, Q. Fan, Gang Li, T. Tang (2009)
Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis.Cancer letters, 281 1
N. Carter, Simi Ali, J. Kirby (2003)
Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphateJournal of Cell Science, 116
S. Weis, D. Cheresh (2011)
Tumor angiogenesis: molecular pathways and therapeutic targetsNature Medicine, 17
Sami Almalki, D. Agrawal (2016)
Effects of matrix metalloproteinases on the fate of mesenchymal stem cellsStem Cell Research & Therapy, 7
Yuanzheng Yang, Gangxiong Huang, Zhichao Zhou, J. Fewell, E. Kleinerman (2017)
miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating FAS Promoter Activity and Can be Therapeutically Targeted to Inhibit Lung MetastasesMolecular Cancer Therapeutics, 17
M. Barreiro, Arcos bullet, H. Sterle, bullet Vercelli, bullet Valli, bullet Cayrol, bullet Klecha, M. Paulazo, bullet Diaz, Flaqué bullet, A. Franchi, G. Cremaschi (2013)
Induction of apoptosis in T lymphoma cells by long-term treatment with thyroxine involves PKCζ nitration by nitric oxide synthaseApoptosis, 18
S. Jia, H. Guan, X. Duan, E. Kleinerman (2008)
VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells.Journal of experimental therapeutics & oncology, 7 2
Sourabh Ghosh, M. Joshi, D. Ivanov, C. Feder-Mengus, G. Spagnoli, I. Martin, P. Erne, T. Resink (2007)
Use of multicellular tumor spheroids to dissect endothelial cell–tumor cell interactions: A role for T‐cadherin in tumor angiogenesisFEBS Letters, 581
L. Kager, A. Zoubek, M. Dominkus, S. Lang, N. Bodmer, G. Jundt, T. Klingebiel, H. Jürgens, H. Gadner, S. Bielack (2010)
Osteosarcoma in very young childrenCancer, 116
J. Morales-Arias, P. Meyers, M. Bolontrade, N. Rodriguez, Zhichao Zhou, Krishna Reddy, A. Chou, N. Koshkina, E. Kleinerman (2007)
Expression of granulocyte‐colony‐stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimensCancer, 110
R. Langley, Karen Ramirez, R. Tsan, Melissa Arsdall, M. Nilsson, I. Fidler (2003)
Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis.Cancer research, 63 11
M. Soto, S. Serres, D. Anthony, N. Sibson (2013)
Functional role of endothelial adhesion molecules in the early stages of brain metastasisNeuro-Oncology, 16
Mariana Garcia, L. Alaniz, E. Lopes, G. Blanco, S. Hajos, É. Álvarez (2005)
Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines.Leukemia research, 29 12
A. Byrne, D. Bouchier‐Hayes, J. Harmey (2005)
Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)Journal of Cellular and Molecular Medicine, 9
Osteosarcoma (OS) is the most frequent malignant bone tumor, affecting predominantly children. Metastases represent a major clinical challenge and an estimated 80% would present undetectable micrometastases at diagnosis. The identification of metastatic traits and molecules would impact in micrometastasis management. We demonstrated that OS LM7 metastatic cells secretome was able to induce microvascular endothelium cell rearrangements, an angiogenic-related trait. A proteomic analysis indicated a gain in angiogenic-related pathways in these cells, as compared to their parental-non-metastatic OS SAOS2 cells counterpart. Further, factors with proangiogenic functions like VEGF and PDGF were upregulated in LM7 cells. However, no differential angiogenic response was induced by LM7 cells in vivo. Regulation of the Fas–FasL axis is key for OS cells to colonize the lungs in this model. Analysis of the proteomic data with emphasis in apoptosis pathways and related processes revealed that the percentage of genes associated with those, presented similar levels in SAOS2 and LM7 cells. Further, the balance of expression levels of proteins with pro- and antiapoptotic functions in both cell types was subtle. Interestingly and of relevance to the model, Fas associated Factor 1 (FAF1), which participates in Fas signaling, was present in LM7 cells and was not detected in SAOS2 cells. The subtle differences in apoptosis-related events and molecules, together with the reported cell-survival functions of the identified angiogenic factors and the increased survival features that we observed in LM7 cells, suggest that the gain in angiogenesis-related pathways in metastatic OS cells would relate to a prosurvival switch rather to an angiogenic switch as an advantage feature to colonize the lungs. OS metastatic cells also displayed higher adhesion towards microvascular endothelium cells suggesting an advantage for tissue colonization. A gain in angiogenesis pathways and molecules does not result in major angiogenic potential. Together, our results suggest that metastatic OS cells would elicit signaling associated to a prosurvival phenotype, allowing homing into the hostile site for metastasis. During the gain of metastatic traits process, cell populations displaying higher adhesive ability to microvascular endothelium, negative regulation of the Fas–FasL axis in the lung parenchyma and a prosurvival switch, would be selected. This opens a new scenario where antiangiogenic treatments would affect cell survival rather than angiogenesis, and provides a molecular panel of expression that may help in distinguishing OS cells with different metastatic potential.
Apoptosis – Springer Journals
Published: May 22, 2021
Keywords: Osteosarcoma; Prosurvival phenotype; Apoptosis; Metastasis; Angiogenesis
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.